Ono to Expand Cancer-Specialized Rep Force to 150 by October Aiming for Additional Indications for Opdivo

Ono President Gyo Sagara Ono Pharmaceutical will increase the number of its cancer-specialized sales reps from 30 at present to 150 by October this year, President Gyo Sagara said at a business briefing on May 12. The company obtained approval...read more